Premium
Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission
Author(s) -
Giordano Roberta,
Picu Andreea,
Marinazzo Elisa,
D’Angelo Valentina,
Berardelli Rita,
Karamouzis Ioannis,
Forno Daniela,
Zinnà Domenico,
Maccario Mauro,
Ghigo Ezio,
Arvat Emanuela
Publication year - 2011
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2011.04055.x
Subject(s) - medicine , endocrinology , metabolic syndrome , cushing's disease , impaired glucose tolerance , waist , diabetes mellitus , adrenal adenoma , disease , cushing syndrome , gastroenterology , adenoma , insulin resistance , obesity
Summary Objective Cushing’s syndrome is associated with several comorbidities responsible for the increased cardiovascular risk, not only during the active phase but also after disease remission. Design In 29 patients with Cushing’s syndrome (14 Cushing’s diseases and 15 adrenal adenomas), waist circumference, fasting and 2‐h glucose after oral glucose tolerance test (OGTT), lipid profile and blood pressure were evaluated during the active disease and 1 year after remission and compared with those in 29 sex‐, age‐ and BMI‐matched controls. Results During the active disease, waist circumference, 2‐h glucose after OGTT, total and LDL cholesterol were higher in patients with Cushing’s syndrome than in controls ( P < 0·001) but similar in Cushing’s disease and adrenal adenomas. The prevalence of impaired glucose tolerance (IGT), diabetes mellitus, dyslipidaemia and hypertension was higher ( P < 0·001) in patients with Cushing’s syndrome (27%, 24%, 59% and 72%) than in controls (10%, 0%, 21% and 10%), with no significant difference between Cushing’s disease and adrenal adenomas. One year following hormonal remission, waist circumference persisted higher than in controls ( P < 0·05) in both Cushing’s disease and adrenal adenomas. Metabolic and cardiovascular abnormalities were still present in both groups, although with a lower prevalence, as well as with a more marked decrease in adrenal adenomas ( P < 0·05 vs active disease for IGT, dyslipidaemia and hypertension). Conclusions These results show that chronic hypercortisolism, independently of its aetiology, contributes to metabolic impairment and increased cardiovascular risk, while these abnormalities mostly persist in patients with previous Cushing’s disease after hormonal remission. Pituitary hormonal deficiencies, hormonal replacement treatments and/or incomplete cure from Cushing’s disease may account for these findings.